(Bloomberg) — The ugliest year ever for US corporate-bond investors is expected to get uglier — and they only have the Federal Reserve to blame. With the central bank raising interest rates at the fastest pace in decades, nearly three quarters of those who responded to the MLIV Pulse survey said that tighter monetary policy […]
Read More(Bloomberg) — The wild ride that bond traders have been on is far from over as market expectations for the longer-term path of Federal Reserve monetary policy appear at odds with the central bank’s own view. Short-dated Treasury yields have alternately plunged and surged in the past few weeks as investors have tried to determine […]
Read More(Bloomberg) — Stocks in Asia look set for a cautious start on Monday following a jump in Treasury yields and the dollar on expectations of further aggressive Federal Reserve interest-rate hikes to tame elevated inflation. Futures dipped for Japan, Australia and Hong Kong, while S&P 500 and Nasdaq 100 contracts declined. Global shares completed a […]
Read MoreTrevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. TRVI $3.9100 0.2800 % 7.7100 Trevi Therapeutics Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 7.71% Wk: 27.78% Mo: -1.01% Yrly: 96.48% […]
Read MoreCanadian National Railway Company (CNI) Canadian National Railway Company, together with its subsidiaries, engages in the rail and related transportation business. The company’s portfolio of goods includes petroleum and chemicals, grain and fertilizers, coal, metals and minerals, forest products, intermodal, and automotive products serving exporters, importers, retailers, farmers, and manufacturers. Canadian Pacific Railway Limited (CP) […]
Read More